Mayumi Squalene, Deep Sea Shark Liver Oil Extract 120 Capsules, high quality and best price
Squalene is an intermediate in the cholesterol
biosynthesis pathway. It was so named because of its occurrence in shark liver
oil, which contains large quantities and is considered its richest source.
However, it is widely distributed in nature, ands found in olive oil, palm oil,
wheat-germ oil, amaranth oil, and rice bran oil. Squalene, the main component of
skin surface polyunsaturated lipids, shows some advantages for the skin as an
emollient and antioxidant, and for hydration and its antitumor activities. It is
also used as a material in topically applied vehicles such as lipid emulsions.
Purchase Mayumi Squalene, Deep Sea Shark Liver Oil Extract Product of Japan

Buy Mayumi Squalene pills and supplement on sale today
This Squalene is 99.9% pure and extracted from liver oil of Aizame sharks, who
inhabit non-polluted waters at depths of 3,000 feet. This superior natural oil
is a product of Japan. Great care is taken in it's preparation to insure potency
and stability.
Suggested Use:
As a nutritional supplement for adults, take one to three Mayumi Squalene, Deep Sea
Shark Liver Oil Extract capsules daily with meals.
Mayumi Squalene, Deep Sea Shark Liver Oil Extract
Supplement Facts
Serving Size: 1 Capsule
Amount Per Serving % DV
Squalene 450 mg ††
††Daily Value Not Established.
No vitamins A, D artificial colors or flavors.
Mayumi Squalene, Deep Sea Shark Liver Oil Extract
Mangosteen home
Buy Mayumi Squalene supplement, deep sea shark liver oil extract
Can fish oils be
taken together with this product?
Probably, we don't see why they can't be taken the same day.
Vaccination, squalene and anti-squalene antibodies:
facts or fiction?
Eur J Intern Med. 2010 Apr; Lippi G, Targher G, Franchini M.U.O. Diagnostica
Ematochimica, Dipartimento di Patologia e Medicina di Laboratorio, Azienda
Ospedaliero-Universitaria di Parma, Parma, Italy.
Squalene, a hydrocarbon obtained for commercial purposes primarily from shark
liver oil and other botanic sources, is increasingly used as an immunologic
adjuvant in several vaccines, including seasonal and the novel influenza A
(H1N1) 2009 pandemic flu vaccines. Nearly a decade ago, squalene was supposed to
be the experimental anthrax vaccine ingredient that caused the onset of Persian
Gulf War syndrome in many veterans, since antibodies to squalene were detected
in the blood of most patients affected by this syndrome. This evidence has
raised a widespread concern about the safety of squalene containing adjuvants
(especially MF59) of influenza vaccines. Nevertheless, further clinical evidence
clearly suggested that squalene is poorly immunogenic, that low titres of
antibodies to squalene can be also detected in sera from healthy individuals,
and that neither the presence of anti-squalene antibodies nor their titre is
significantly increased by immunization with vaccines containing squalene (or
MF59) as an adjuvant. This review summarizes the current scientific evidence
about the relationship between squalene, anti-squalene antibodies and
vaccination.